Download
1 / 4
40 likes | 52 Views
Global huntingtonu2019s disease therapeutics market is anticipated to grow at a steady CAGR in future. Hungtingtonu2019s disease (HD) is mainly prevalent in adults which is chronic and progressively neurodegenerative disease by nature.
E N D
Global Huntington's Disease Therapeutics Market Research Report 2016-2021 by Radiant Insights, Inc Global huntington’s disease therapeutics market is anticipated to grow at a steady CAGR in future. Hungtington’s disease (HD) is mainly prevalent in adults which is chronic and progressively neurodegenerative disease by nature. April 15, 2019: Global huntington’s disease therapeutics market is anticipated to grow at a steady CAGR in future. Hungtington’s disease (HD) is mainly prevalent in adults which is chronic and progressively neurodegenerative disease by nature. Medically, it is characterized by choreic involuntary movements followed by psychiatric, psychological and intellectual disorders and mainly characterized radiologically by striatal atrophy of varying degree. Genetically, hungtington’s disease is an autosomal – dominantly inherited type of disease.HD can be looked upon as a model neurodegenerative disorder. Determination of biomarkers that can reliably sense subtle changes of disease progression in order to be able to precisely assess the effects of disease-modifying therapeutics. Certain biomarkers comprising cognitive, clinical,behavioralneuro- imaging and neurophysiological phase need to be assessed during the detection of premotor phase. Request a Sample Copy Of This Report @: https://www.radiantinsights.com/research/global-huntington-s-disease- therapeutics-2016/request-sample HD diseases result in certain motor impairments and thus neurophysiological assessment of central nervous system that need potential evaluation. Prevalence of hungtington’sdisease is common in adult age group from 30-40 years and patients beyond 40 or 50 are even diagnosed with some extra medications. Hence, it is likely that the ratio of laterecipients of HD may get highlighted owing to aging population. Follow Us:
Commercial market driving factors responsible for the growth of hungtington’s disease include unmet medical needs, rise in pharmaceuticals and inception of innovative drugs. However, stringent regulations by government coupled with minimal approval for drugs hampers the market growth in the estimated period. Geographically, the huntington’s disease therapeutics market spans North America, Latin America, Europe, Middle-East, Asia-Pacific and Africa. North America dominated the global market owing to rising cases of the disease and therapy for the same. Europe and MEA regions however witnessed a steady CAGR growth. APAC regions also exhibited a steady CAGR growth rate in the estimated period owing to rising cases of hungtington’s disease. Browse Full Research Report @: https://www.radiantinsights.com/research/global-huntington-s-disease- therapeutics-2016 The key players in the hungtington’s diseases therapeutics market include Valeant Pharmaceuticals International Inc., Alnylam Pharmaceuticals Inc., AmpliPhi Biosciences Corp, Ceregene Inc., Lundbeck, Prana Biotechnology Limited, Teva Pharmaceutical Industries Ltd., Cortex Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Auspex Pharmaceuticals, SOM Biotech, GlaxoSmithKline, Siena Biotech, Raptor Pharmaceutical, Pfizer, Palobiofarma, Omeros and Ipsen. Table of Contents Global Huntington's Disease Therapeutics Market Research Report 2016 1 Huntington's Disease Therapeutics Market Overview 1.1 Product Overview and Scope of Huntington's Disease Therapeutics 1.2 Huntington's Disease Therapeutics Segment by Type 1.2.1 Global Production Market Share of Huntington's Disease Therapeutics by Type in 2015 1.2.2 Type I 1.2.3 Type II 1.2.4 Type III 1.3 Huntington's Disease Therapeutics Segment by Application 1.3.1 Huntington's Disease Therapeutics Consumption Market Share by Application in 2015 1.3.2 Application 1 1.3.3 Application 2 1.3.4 Application 3 1.4 Huntington's Disease Therapeutics Market by Region 1.4.1 North America Status and Prospect (2011-2021) 1.4.2 Europe Status and Prospect (2011-2021) 1.4.3 China Status and Prospect (2011-2021) 1.4.4 Japan Status and Prospect (2011-2021) 1.4.5 Southeast Asia Status and Prospect (2011-2021) 1.4.6 India Status and Prospect (2011-2021) 1.5 Global Market Size (Value) of Huntington's Disease Therapeutics (2011-2021) Follow Us:
2 Global Huntington's Disease Therapeutics Market Competition by Manufacturers 2.1 Global Huntington's Disease Therapeutics Production and Share by Manufacturers (2015 and 2016) 2.2 Global Huntington's Disease Therapeutics Revenue and Share by Manufacturers (2015 and 2016) 2.3 Global Huntington's Disease Therapeutics Average Price by Manufacturers (2015 and 2016) 2.4 Manufacturers Huntington's Disease Therapeutics Manufacturing Base Distribution, Sales Area and Product Type 2.5 Huntington's Disease Therapeutics Market Competitive Situation and Trends 2.5.1 Huntington's Disease Therapeutics Market Concentration Rate 2.5.2 Huntington's Disease Therapeutics Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Huntington's Disease Therapeutics Production, Revenue (Value) by Region (2011- 2016) 3.1 Global Huntington's Disease Therapeutics Production and Market Share by Region (2011-2016) 3.2 Global Huntington's Disease Therapeutics Revenue (Value) and Market Share by Region (2011- 2016) 3.3 Global Huntington's Disease Therapeutics Production, Revenue, Price and Gross Margin (2011- 2016) 3.4 North America Huntington's Disease Therapeutics Production, Revenue, Price and Gross Margin (2011-2016) 3.5 Europe Huntington's Disease Therapeutics Production, Revenue, Price and Gross Margin (2011- 2016) 3.6 China Huntington's Disease Therapeutics Production, Revenue, Price and Gross Margin (2011- 2016) 3.7 Japan Huntington's Disease Therapeutics Production, Revenue, Price and Gross Margin (2011- 2016) 3.8 Southeast Asia Huntington's Disease Therapeutics Production, Revenue, Price and Gross Margin (2011-2016) 3.9 India Huntington's Disease Therapeutics Production, Revenue, Price and Gross Margin (2011- 2016) 4 Global Huntington's Disease Therapeutics Supply (Production), Consumption, Export, Import by Regions (2011-2016) 4.1 Global Huntington's Disease Therapeutics Consumption by Regions (2011-2016) 4.2 North America Huntington's Disease Therapeutics Production, Consumption, Export, Import by Regions (2011-2016) 4.3 Europe Huntington's Disease Therapeutics Production, Consumption, Export, Import by Regions (2011-2016) 4.4 China Huntington's Disease Therapeutics Production, Consumption, Export, Import by Regions (2011-2016) 4.5 Japan Huntington's Disease Therapeutics Production, Consumption, Export, Import by Regions (2011-2016) Read all Reports of this category @ https://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare Follow Us:
About Radiant Insights, Inc: Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. Contact Details: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc 201 Spear St #1100, Suite #3036, San Francisco, CA 94105, United States Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: sales@radiantinsights.com Web: http://www.radiantinsights.com/ Follow Us:
